Helius Medical Technologies Inc (HSDT)
1.82
-0.06
(-3.19%)
USD |
NASDAQ |
May 08, 16:00
1.82
0.00 (0.00%)
After-Hours: 17:17
Helius Medical Technologies Revenue (Quarterly): 0.134M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.134M |
September 30, 2023 | 0.143M |
June 30, 2023 | 0.256M |
March 31, 2023 | 0.111M |
December 31, 2022 | 0.282M |
September 30, 2022 | 0.196M |
June 30, 2022 | 0.119M |
March 31, 2022 | 0.19M |
December 31, 2021 | 0.258M |
September 30, 2021 | 0.109M |
June 30, 2021 | 0.071M |
Date | Value |
---|---|
March 31, 2021 | 0.084M |
December 31, 2020 | 0.191M |
September 30, 2020 | 0.131M |
June 30, 2020 | 0.133M |
March 31, 2020 | 0.207M |
December 31, 2019 | 0.152M |
September 30, 2019 | 0.15M |
June 30, 2019 | 0.518M |
March 31, 2019 | 0.677M |
December 31, 2018 | 0.478M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.071M
Minimum
Jun 2021
0.518M
Maximum
Jun 2019
0.1808M
Average
0.15M
Median
Sep 2019
Revenue (Quarterly) Benchmarks
ARCA biopharma Inc | -- |
Cerus Corp | 38.36M |
NeuroOne Medical Technologies Corp | 0.9776M |
Perspective Therapeutics Inc | -5.239M |
Electromed Inc | 13.69M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -1.045M |
Total Expenses (Quarterly) | 2.38M |
EPS Diluted (Quarterly) | -0.96 |
Enterprise Value | -3.513M |
Gross Profit Margin (Quarterly) | 32.84% |
Profit Margin (Quarterly) | -779.9% |
Earnings Yield | -766.5% |
Normalized Earnings Yield | -1055.30 |